Event JSON
{
"id": "02881687d8a4e337ac0708fe57ceafaa06f637eecb3591223a52fce6366db1d1",
"pubkey": "b8f79cff66b2e593b08a5eba662e9dcbf3b626d5652e61b3b8cd8950a7733a38",
"created_at": 1735047285,
"kind": 1,
"tags": [
[
"r",
"https://finance.yahoo.com/news/salesforce-stokes-fight-veeva-snagging-130000426.html"
],
[
"subject",
"Salesforce Stokes Fight With Veeva by Snagging Drug Customers"
],
[
"published_at",
"1735045200"
],
[
"image",
"https://s.yimg.com/ny/api/res/1.2/VExNU5ydhKrlaAsnW.hSrQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/bloomberg_markets_842/83f9e10276e07859261e7a02019c2dbd"
],
[
"p",
"b8f79cff66b2e593b08a5eba662e9dcbf3b626d5652e61b3b8cd8950a7733a38",
"wss://articles.layer3.news"
],
[
"imeta",
"url https://s.yimg.com/ny/api/res/1.2/VExNU5ydhKrlaAsnW.hSrQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/bloomberg_markets_842/83f9e10276e07859261e7a02019c2dbd"
],
[
"t",
"Technology:perspective"
],
[
"summary",
"Salesforce is developing a life sciences product to compete with Veeva's customer relationship management software, which has a market share of over 80%. The companies had a nonaggression treaty dating back to 2007, but Veeva ended it in late 2022, allowing Salesforce to develop a competing offering. Salesforce claims to have signed deals with over 40 customers, including a top three global pharma leader, and is staffing development teams at a rapid rate for the new product."
]
],
"content": "nostr:nprofile1qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqhrmeelmxktje8vy2t6axvt5ae0emvfk4v5hxrvaceky4pfmn8guq4j834n\nhttps://s.yimg.com/ny/api/res/1.2/VExNU5ydhKrlaAsnW.hSrQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/bloomberg_markets_842/83f9e10276e07859261e7a02019c2dbd\n\nhttps://finance.yahoo.com/news/salesforce-stokes-fight-veeva-snagging-130000426.html",
"sig": "206fbe51a59048056a2f09bb72e1ce5b89956d1ecbde9aa554b2bf9714c1d10dddc3454cef86fad87a84268be261687c752c86921e5d7ade70bfa2585d9a6115"
}